Benzinga’s Top Downgrades (IMGN, VSAT, CHIND, GD)

ImmunoGen Inc

was downgraded by RBC Capital from “outperform” to “sector perform.” IMGN’s shares dipped 37.54% to $5.24 at 11:31 am. ImmunoGen’s trailing-twelve-month profit margin is -365.14%. Stephens downgraded ViaSat Inc

from "overweight" to "equal weight." VSAT’s shares gained 0.35% to $34.90. ViaSat’s quarterly earnings dipped 69.40% y/y. Raymond James downgraded CDC Corporation

from "outperform" to "market perform." CHIND’s stock lost 8.52% to $4.19. CDC’s quarterly revenue moved down 3.80% y/y. General Dynamics Corporation

was downgraded by Argus from “buy” to “hold.” GD’s shares fell 0.05% to $56.80. General Dynamics’ earnings are likely to fall by 0.15% this year.